NEUROPATHY RESEARCH CENTER
Neuropathy Research Center
In collaboration with neurologists, endocrinologists, other physicians, and basic scientists, the Columbia Neuropathy Research Center (CNRC) is committed to basic and human research designed to improve our understanding and effective treatment of peripheral and autonomic neuropathies of all types.
Clifton L. Gooch, M.D.
Dr. Gooch is the founder and director of the Columbia Neuropathy Research Center (CNRC) and the Electromyography Laboratory for the Columbia University Department of Neurology and for New York Presbyterian Hospital. He has over a decade of experience in therapeutic clinical trials, as well as the neurophysiologic investigation of nerve and muscle function. His research has focused on the development of new diagnostic technologies and experimental therapies for neuropathy and other neuromuscular diseases (including Lou Gehrig's disease and myasthenia gravis) and on understanding the molecular basis of peripheral neuropathies, resulting in over 100 publications and abstracts. He is a member of the Board of Directors for the American Association of Neuromuscular and Electrodiagnostic Medicine, Editor-in-Chief of the journal: Advances in Immunotherapy and President of the American Academy of Immunotherapy, among many other accomplishments. He holds three board certifications (Neurology, Clinical Neurophysiology, and Electromyography), and serves as an advisory board member for numerous medical journals and societies.
Louis Weimer, M.D.
Dr. Weimer is Co-Director of the CNRC and additionally directs the Clinical Autonomic Laboratory. His clinical and research interests include testing of autonomic and small nerve fiber function, dysautonomia, small fiber neuropathy, neurologic causes of syncope, and autonomic failure syndromes. Other special interests include neuropathy from medications and toxins, entrapment neuropathies, and the myopathy of critical illness. He has participated in numerous clinical trials of various neuromuscular disorders, including diabetic and HIV-related neuropathy, Lou Gehrig's disease, and others; he has published over 90 peer reviewed papers, invited reviews, book chapters, and meeting abstracts to date. Dr. Weimer is the current chairman of the national Training Program Committee for the American Association of Neuromuscular and Electrodiagnostic Medicine; he is a member of the national medical advisory board for the Charcot-Marie-Tooth Association (CMTA); and is a frequent oral board examiner for the American Board of Electrodiagnostic Medicine. He is a senior editor of Medlink neurology and serves as the chairman of the quality assurance and improvement committee for the Department of Neurology. In addition to autonomic and neuromuscular patient testing, Dr. Weimer sees select patients for an initial diagnostic consultation, in most instances patients with various forms of autonomic dysfunction.
Aging, Memory & Dementia